United States · Series B startup

Who invested in Traversa Therapeutics

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$7.0Mraised across 2 rounds since 2008, from 2 sources

$2.0MSeries A$5.0MSeries B
Latest round
Series B, $5.0MApr 2009
Step-upi
2.5×
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2009
$2.0MSeries A$5.0MSeries B
First round
Series A, $2.0M
Feb 2008
Biggest round
$5.0M
Series B · Apr 2009
Between rounds
14 months
from the last two

The rounds

  1. Apr 2009
    Series B$5.0M1 new1 returning

    Reported by traversathera.com

  2. Feb 2008

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Traversa Therapeutics

Who invested in Traversa Therapeutics?

Traversa Therapeutics's investors include Morningside Group, Tech Coast Angels and Mesa Verde Venture Partners.

How much has Traversa Therapeutics raised?

Traversa Therapeutics has raised $7.0M across 2 rounds since 2008.

When did Traversa Therapeutics last raise?

Traversa Therapeutics's most recent round was a Series B of $5.0M in Apr 2009.

What was Traversa Therapeutics's biggest round?

Its most recent round, $5.0M in Apr 2009, is also its largest on record.

Who backed Traversa Therapeutics first?

Traversa Therapeutics's first round on record, in Feb 2008, was backed by Tech Coast Angels and Morningside Group.

What stage is Traversa Therapeutics at?

Traversa Therapeutics's latest named round is a Series B, in Apr 2009.

Where is Traversa Therapeutics based?

Traversa Therapeutics is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.